Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review

OBJECTIVES: Molecular biomarker tests can inform the clinical management of genomic heterogeneous hematological malignancies, yet their availability in routine care largely depends on the supporting health economic evidence. This study aims to systematically review the economic evidence for recent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Martin, Degeling, Koen, Thompson, Ella R., Blombery, Piers, Westerman, David, IJzerman, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310724/
https://www.ncbi.nlm.nih.gov/pubmed/35158410
http://dx.doi.org/10.1111/ejh.13755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310724/
https://www.ncbi.nlm.nih.gov/pubmed/35158410
http://dx.doi.org/10.1111/ejh.13755

Ejemplares similares